// App-Quantinova.ai

10 : Silibinin exhibits anti-cachectic and anti-cancerous property by modulating metabolic properties of pancreatic cancer cells

Researchers

Presenter

  • Surendra K. Shukla

Principal Investigators

  • Aneesha Dasgupta

  • Kamiya Mehla

  • Venugopal Gunda

  • Enza Vernucci

  • Joshua Soucheck

  • Gennifer Goode

  • Ryan King

  • Anusha Mishra

  • Ibha Rai

  • Sangeetha Natrajan

  • Nina Chaika

  • Fang Yu

  • Pankaj K. Singh

Medical Centers

  • UNMC Eppley Inst. for Cancer Research, Omaha, NE.

  • Department of Biostatistics, UNMC, Omaha, NE.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Cancer related cachexia

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • Silibinin

  • Milk thistle

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved